NIVA BUPA HEALTH INS CO L Latest Share Price (NIVABUPA)
TODAY IN ONE LINE
NIVABUPA fell 1.9% on light volume, lagging Nifty's -0.6% move.
With a market cap of ₹14,923.32 Cr., it trades at a P/E of 116.18. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
NIVA BUPA HEALTH INS CO L flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 90.2% YoY
- ●High Promoter HoldingPromoters hold 55.3% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.07x
- ●FII AccumulationFII holding increased by 1.49% QoQ
- ●Promoter BuyingPromoters increased holdings by 55.30% QoQ
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
Latest NIVA BUPA HEALTH INS CO L News
What changed recently?
Recent events, corporate actions, and announcements.
NIVA BUPA HEALTH INS CO L valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for NIVA BUPA HEALTH INS CO L, framed against the sector median so the premium or discount is obvious at a glance.
NIVA BUPA HEALTH INS CO L trades at a P/E of 116.18× and P/B of 4.00×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
NIVA BUPA HEALTH INS CO L technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for NIVA BUPA HEALTH INS CO L — derived from the latest tape, not yesterday's close.
NIVA BUPA HEALTH INS CO L last traded at ₹80.73 with an intraday range of ₹80.51–₹83.47 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹80.73| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 88.55 | +7.82 | +9.69% |
| R3 | 85.59 | +4.86 | +6.02% |
| R2 | 84.53 | +3.80 | +4.71% |
| R1 | 82.63 | +1.90 | +2.35% |
| PIVOT | 81.57 | 0.84 | 1.04% |
| CURRENT | 80.73 | — | — |
| S1 | 79.67 | -1.06 | -1.31% |
| S2 | 78.61 | -2.12 | -2.63% |
| S3 | 76.71 | -4.02 | -4.98% |
| S4 | 73.75 | -6.98 | -8.65% |
NIVABUPA is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹81.41–₹83.47
Trading Inside opening range
NIVA BUPA HEALTH INS CO L financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for NIVA BUPA HEALTH INS CO L — consolidated or standalone — with margins, YoY growth and key ratios inline.
NIVA BUPA HEALTH INS CO L reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹14,923.32 Cr. and reported EPS of ₹1.87.
NIVA BUPA HEALTH INS CO L segment analysis : revenue and profit mix.
Disclosed business segments at NIVA BUPA HEALTH INS CO L with their share of revenue and profit, switchable between consolidated and standalone reporting.
NIVA BUPA HEALTH INS CO L discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for NIVA BUPA HEALTH INS CO L.
Our AI distills the core fundamental drivers supporting NIVA BUPA HEALTH INS CO L, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
NIVA BUPA HEALTH INS CO L's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
TTM revenue growth of 26.8% YoY demonstrates strong market traction post-IPO.
Latest quarterly EPS grew 89.3% YoY, signaling improving earnings momentum significantly.
Operating margin of 8.47% with strong operating cash flow of ₹904.86 Cr.
Debt-to-equity ratio of 0.0007x ensures fortress-like balance sheet resilience.
Promoter holding of 55.3% reflects strong founder commitment and long-term alignment.
Key Risks.
P/E ratio of 122.25x significantly overvalued versus sector peer medians substantially.
Quarterly PAT swung to loss of ₹91.4 Cr, reflecting severe earnings volatility.
Zero dividend yield limits income appeal for dividend-seeking investors significantly.
ROE of 3.82% and ROCE of 3.45% lag peer medians substantially and concerning.
EV/EBITDA of 31.53x far exceeds peer median of 6.98x, indicating overvaluation.
Flip Conditions.
Valuation risk. a P/E above 151 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
NIVA BUPA HEALTH INS CO L peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — NIVA BUPA HEALTH INS CO L is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
NIVA BUPA HEALTH INS CO L chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for NIVA BUPA HEALTH INS CO L — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
NIVA BUPA HEALTH INS CO L delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for NIVA BUPA HEALTH INS CO L over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in NIVA BUPA HEALTH INS CO L stood at 43.5% of traded volume, against a 20-day average of 53.5%.
NIVA BUPA HEALTH INS CO L announcements: results, concalls, ratings, M&A.
Filings NIVA BUPA HEALTH INS CO L sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
NIVA BUPA HEALTH INS CO L files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 162 documents below.
ESOP/ESOS/ESPS
Niva Bupa Health Insurance Company Limited has informed the Exchange regarding Allotment of 4,11,000 Equity Shares.
Credit Rating
Niva Bupa Health Insurance Company Limited has informed the Exchange about Credit Rating
Action(s) taken or orders passed
Niva Bupa Health Insurance Company Limited has informed the Exchange about receipt of the Order from the Insurance Regulatory and Development…
Shareholders meeting
Niva Bupa Health Insurance Company Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on August 12, 2026
Shareholders meeting
Niva Bupa Health Insurance Company Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 12, 2026
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
NIVA BUPA HEALTH INS CO L dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue NIVA BUPA HEALTH INS CO L has declared, sequenced by announce and record date.
NIVA BUPA HEALTH INS CO L corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
NIVA BUPA HEALTH INS CO L insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in NIVA BUPA HEALTH INS CO L as reported to SEBI — buying and selling signals from the people who know the business best.
NIVA BUPA HEALTH INS CO L insider activity below tracks 1 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Vikas Gupta | Insider | 26 Dec 2024 | sell | −40.0 K | ₹32.25 L | ₹80.63 |
About NIVA BUPA HEALTH INS CO L: business, sector, key facts.
What NIVA BUPA HEALTH INS CO L does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
NIVA BUPA HEALTH INS CO L operates in the General Insurance industry under the Financial Services sector, listed as NSE: NIVABUPA, BSE: 544286.
Niva Bupa Health Insurance Company Limited is a prominent health insurance provider operating within the Indian market. Their core business revolves around offering a comprehensive suite of health insurance products designed to cater to diverse individual and family needs. This includes a range of plans encompassing individual health insurance, family floater plans offering coverage for multiple family members, critical illness coverage designed to financially protect against serious diseases, and personal accident insurance to address unforeseen injuries.
A key aspect of Niva Bupa's business model is the underwriting of these various insurance plans. Underwriting involves assessing risk and determining the appropriate premiums for each policy based on factors such as age, health status, and the level of coverage requested. This process ensures that the company can accurately price its policies while maintaining financial stability and offering competitive rates to its customers.
Beyond core health insurance, Niva Bupa also extends its services to include travel insurance. This type of insurance offers coverage for medical emergencies, trip cancellations, and other unforeseen events that may arise during travel, providing valuable peace of mind to individuals traveling both domestically and internationally. The inclusion of travel insurance demonstrates Niva Bupa's commitment to providing a broad spectrum of risk management solutions.
The company's history stretches back to 1947, showcasing a significant presence within the Indian insurance sector. While undergoing a name change from Max Bupa Health Insurance Company Limited to Niva Bupa Health Insurance Company Limited in July 2021, the core business and commitment to providing comprehensive health insurance solutions remain unchanged. Currently headquartered in Gurugram, India, Niva Bupa operates as a subsidiary of Bupa Singapore Holdings Pte. Ltd., leveraging international expertise and resources to enhance its offerings and market position within the competitive Indian health insurance landscape.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- ADVIK CAPITAL (ADVIKCA) Share PricePeer
- AUTHUM INVEST & INFRA (AIIL) Share PricePeer
- A K CAPITAL SERVICES (AKCAPIT) Share PricePeer
- ALFRED HERBERT INDIA L (ALFREDHE) Share PricePeer
- ALGOQUANT FINTECH (ALGOQUANT) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about NIVA BUPA HEALTH INS CO L (NIVABUPA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of NIVA BUPA HEALTH INS CO L (NIVABUPA)?
The current share price of NIVA BUPA HEALTH INS CO L (NIVABUPA) is ₹80.73. Today, the stock has declined by ₹1.57 (1.91%), trading in a range of ₹80.51 to ₹83.47. The stock opened at ₹83.00 with a trading volume of 3,65,819 shares.
02Is NIVA BUPA HEALTH INS CO L stock a good investment for long-term?
NIVA BUPA HEALTH INS CO L can be considered for long-term investment based on several factors. The company has a market capitalization of ₹14,923.32 Cr., P/E ratio of 116.18, ROE of 0%, and ROCE of 0%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of NIVA BUPA HEALTH INS CO L stock?
The 52-week high price of NIVA BUPA HEALTH INS CO L (NIVABUPA) is ₹91.40, while the 52-week low is ₹67.50. Currently trading at ₹80.73, the stock is 19.6% above its 52-week low and 11.67% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy NIVA BUPA HEALTH INS CO L stock at the current price?
Whether to buy NIVA BUPA HEALTH INS CO L stock at ₹80.73 depends on multiple factors. The stock is currently trading with a P/E ratio of 116.18 and P/B ratio of 4. Today's performance shows a loss of 1.91%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of NIVA BUPA HEALTH INS CO L and when is the next dividend?
NIVA BUPA HEALTH INS CO L offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹80.73, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹0.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of NIVA BUPA HEALTH INS CO L?
NIVA BUPA HEALTH INS CO L's key financial metrics include: P/E Ratio: 116.18, P/B Ratio: 4, ROE: 0%, ROCE: 0%, Dividend Yield: 0%, EPS: ₹1.87, Book Value: ₹23.73, and Debt-to-Equity: 0.07. The company's market cap stands at ₹14,923.32 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is NIVA BUPA HEALTH INS CO L stock performing today in the market?
NIVA BUPA HEALTH INS CO L stock opened at ₹83.00 and is currently trading at ₹80.73, showing a decline of ₹1.57 (1.91%). The intraday high is ₹83.47 and low is ₹80.51. The trading volume stands at 3,65,819 shares, indicating moderate market participation today.
08What is the P/E ratio of NIVA BUPA HEALTH INS CO L and what does it indicate?
NIVA BUPA HEALTH INS CO L has a Price-to-Earnings (P/E) ratio of 116.18, which means investors are willing to pay 116.18 for every ₹1 of earnings. With an EPS of ₹1.87, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about NIVA BUPA HEALTH INS CO L (NIVABUPA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.